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Available online 5 November 2016The gene of ATP-binding cassette subfamily C member 8 (Abcc8) is cytogenetically located at 11p15.1 and en-
codes the sulfonylurea receptor (SUR1). SUR1 is a subunit of ATP-sensitive potassium channel (KAPT) in the β-
cell regulating insulin secretion. Mutations of ABCC8 are responsible for congenital hyperinsulinism (CHI).
Here we reported that an Abcc8 heterozygous mutant cell line was generated by CRISPR/Cas9 technique with
1 bp insertion resulting in abnormal splicing on human embryonic stem cell line H1. The phenotypic character-
istics of this cell line reveal defective KATP channel and diazoxide-responsive that provides ideal model for mo-
lecular pathology research and drug screening for CHI.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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H1Abcc8-A2 cell line heterozygousmutation for Abcc8was generat-
ed by targeting exon2 of abcc8 using CRISPR/Cas9 gene edit system
(Fig. 1.A). H1 cells were transfected with Cas9-G418 and 2 sgRNAs plas-
mids targeting two sites on exon2 for double nickase activity. G418 re-
sistance cells were plated ontomatrigel-coated 96-well plates for single
cell selection according to 90 cells per plate. Thirty individual colonies
were picked and expanded for conﬁrmation. Genomic DNAwas isolated
and analyzed by high ﬁdelity PCR ampliﬁcation followed by sequencing
of exon2 of abcc8 at the targeted region. Three heterozygous ES clones
were obtained and one of them, Abcc8-A2, was chosen for further
characterization.
Genome sequencing showed that Abcc8-A2 has heterozygousmuta-
tion with1 base pair insertion (Fig. 1.B). Abcc8-A2 cell line has classical
stem cellmorphologywith a high nuclear to cytoplasmic ratio (Fig. 1.C).
Abcc8-A2 was pluripotent identiﬁed by immunostaining for Oct4 and
Nanog (Fig. 1.D) and has normal karyotype (Fig. 1.E). Furthermore this
cell retained the potential to differentiate into three germ layers upon
embryo body formation in vitro, as showed by RNA expression analysis
(Fig. 1.F).
To test whether off-target effect occurred in Abcc8-A2, a total of 8
potential off-target sites (POTs) for each sgRNA were predicted by the
CRISPR design online tool. All POTs were PCR ampliﬁed and then se-
quenced. Sequencing results showed that no mutation was detected in
these POTs (Fig. S1.A, B), indicating that the Cas9/sgRNA system did
not induce undesirable off-target effect in the abcc8 deﬁcient ES cells.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1.Generation and characterization of the human homozygous embryonic stem cell line Abcc8-A2. (A): Schematic of sgRNAs targeting abcc8. Both of the target loci sites are located in
the second exon. sgRNA targeting sites are highlighted in red. PAM are highlighted in blue and underlined. (B): Sanger-sequencing of targeted colonies identiﬁed by PCR. The wide type
sequence is shown at the top. (C): Abcc8-A2 has heterozygous 1 bp insertion located in the second exon the Abcc8. The black arrow indicates heterozygous 1 base pair (T) insertion. (D):
Image of Abcc8-A2 cell line. The cell has classical stemcellmorphologywith a highnuclear to cytoplasmic ratio. The imageswere takenwith a 10×objective lens. (E): Immunoﬂuorescence
staining of pluripotent markers Oct4 and Nanog. (F): ABCC8-A2 has normal karyotype. (G): qPCR analysis of Abcc8-A2-EB of pluriopitent marker and markers for the three germ layers
relative to Abcc8A-A2 cells (Ectoderm: Sox1 and Pax6; Endoderm: AFP and Sox17; Mesoderm: Tbx1 and MSX1).
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Cells culture
Human embryonic stem cell H1 (Thomson et al., 1998) was routine-
ly maintained on matrigel with mTeSR1 (stem cell). Generally the cells
were passaged about 4 days with accutase (Sigma). Rock inhibitorY27632 (Sigma) was added to improve survival rate for 24 h after
replating.
Targeting strategy with Cas9
Cas9-G418 plasmid was constructed and Abcc8 sgRNAs were de-
signed as the method described in previous report (Zhou et al., 2015).
672 D. Guo et al. / Stem Cell Research 17 (2016) 670–672For targeting, 0.8 million H1 cells were transfected with 4 μg Cas9-G418
plasmid and 1 μg ABCC8 sgRNA plasmid respectively. Then, the cells
were seeded onto matrigel-coated 24-well plate in the presence of
Y27632 (10 μM, Sigma). G418 (100 μg/ml) was added to the cells for se-
lection of 48 h after 24 h for recovery. Then the cells was replated into
96-well plates in the presence of Y27632 for single cell selection with
limited dilution according to 0.8 cell per well. Sequencing was used
for mutation identiﬁcation. The primers used for PCR ampliﬁcation
and sequencing was: forward: 5′ CCAGGCTGAATGAGTTGGAC-3′; re-
verse: 5′-TCTGCTCTCCTGGACTGATG-3′.
Immunoﬂuorescence microscopy
The cells were ﬁxed in 1% paraformaldehyde for 30 min. After
washed with PBS for 3 times, the cells were blocked and permeabilized
in blocking solution (PBS containing 3% Bovine albumin and 0.2% Triton
X-100) for 30 min at room temperature. Then the cells were incubated
with primary antibodies in blocking solution at 4 °C overnight, washed 3
times and incubated with the corresponding secondary antibodies for
1 h at room temperature. The cells were washed twice and stained
with DAPI (Sigma) for 5 min, and then observed using a LEICA
DMI6000B microscope (Leica Microsystems). The following antibodies
and dilutions were used: mouse anti-OCT3/4 (1:200, Santa Cruz), goat
anti-Nanog (1:200, R&D).
Karyotype analysis
Karyotype analysis was completed according to the method de-
scribed by Wen Li (Li et al., 2012). Brieﬂy cells growing in logarithmic
phase in 6 cm-plate were treated with colcemid for 2 h at 37 °C. Cells
were then trypsinized, treated with hypotonic solution for 20 min and
ﬁxed with methanol: acetic acid (3:1). Metaphases were spread on mi-
croscope slides, and chromosomes were classiﬁed according to the In-
ternational System for Human Cytogenic Nomenclature using the
standard G banding technique. At least, 20 metaphases were counted
per cell line, and the ﬁnal karyotype was stated if it was present in
more than 85% of them.
Embryonic body (EB) formation and in vitro differentiation
EB formation was completed according to the method previous re-
portedwith slightmodiﬁcation (Xue et al., 2013). ES colonies onmatrigel
coated platewere incubatedwith collagenase IV (Gibco) for about 30min
at 37 °C till the colonies were completely dissociated. The colonies were
washed with DMEM/F12 and resuspended in EB medium ((DMEM/
F12 + 20%Knockout serum replacement (KSR, Gibco) +1% L-GlutaMax
(Gibco) +1% NEAA (Gibco) +0.1% b-mercaptoethanol (Gibco)).The col-
onies were cultured in suspension for 7 days then transferred onto
matrigel coated plate and cultured for 7 days more. Then the cells were
digest ed and collected for RNA isolation and gene expression analysis.Real-time PCR analysis
Total mRNA was isolated using TRIzol (Invitrogen) following the
manufacturer's instruction and 1 μg of RNA was used for reverse tran-
scription. Real-time PCR analysis was performed on CFX96 machine
(Bio-rad) using the SYBR Green PCR Master Mix (Toyobo). The PCR re-
action consisted of 10 μl of SYBR Green PCR Master Mix, 1 μl of 10 μM
forward and reverse primers, 8 μl of template cDNA diluted 20 times
in a total volume of 20 μl. Cycling was performed using the conditions
of the CFX96 Software: 95 °C 3 min, followed by 40 cycles of 95 °C for
10 s and 60 °C for 30 s. Samples were analyzed in triplicate and normal-
ized on the basis of GAPDH values. The primer sequences are shown in
Supplemental Table 1.
Off target analysis
Eight potential off-target sites (POTs) for each sgRNAwere predicted
to analyze site-speciﬁc cleavage by the CRISPR/Cas9 systemaccording to
an online design tool (http://crispr.cos.uni-heidelberg.de) (Stemmer et
al., 2015). PCR products of the POTS were conﬁrmed by sequencing.
Primers for POTS determination were listed in Supplementary Table 2.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.scr.2016.11.014.
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